Position in VERA
as of Jun 30, 2026
· filed Aug 12, 2026
Position Value
$3,403,063
+$404,520 QoQ
Shares Held
79,307
+6.4% QoQ
Ownership
0.110%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#78
of 217 holders
Holding Since
Mar 2022
18 quarters on record
Voting authority
Sole 22%
Shared 0%
None 78%
Common Shares in VERA Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026RHUMBLINE ADVISERS holds $1,404,724,682 across 329 Biotechnology names. VERA ranks #69 (0.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
396,380 | $196,893,837 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
157,794 | $98,390,870 | |
| 3 | MRNA |
Moderna, Inc.
|
809,853 | $56,714,005 | |
| 4 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
165,579 | $49,844,246 | |
| 5 | INCY |
Incyte Corp
|
428,533 | $48,578,500 | |
| 6 | RVMD |
Revolution Medicines, Inc.
|
226,008 | $42,326,778 | |
| 7 | ROIV |
Roivant Sciences Ltd.
|
1,178,789 | $41,717,342 | |
| 8 | JAZZ |
Jazz Pharmaceuticals plc
|
163,018 | $39,282,447 |
All Filings in VERA
Export CSV
18 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $3,403,063 | 79,307 | Shares | Sole | 2026-08-12 | |
| 2026-03-31 | $2,998,543 | 74,535 | Shares | Sole | 2026-05-12 | |
| 2025-12-31 | $3,368,117 | 66,511 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $2,120,188 | 72,959 | Shares | Sole | 2025-11-06 | |
| 2025-06-30 | $1,768,649 | 75,070 | Shares | Sole | 2025-08-12 | |
| 2025-03-31 | $1,517,799 | 63,189 | Shares | Sole | 2025-05-29 | |
| 2024-12-31 | $2,477,728 | 58,589 | Shares | Sole | 2025-05-29 | |
| 2024-09-30 | $2,301,670 | 52,074 | Shares | Sole | 2024-11-12 | |
| 2024-06-30 | $1,984,798 | 54,859 | Shares | Sole | 2024-08-01 | |
| 2024-03-31 | $2,490,050 | 57,747 | Shares | Sole | 2024-05-09 | |
| 2023-12-31 | $738,224 | 47,999 | Shares | Sole | 2024-02-08 | |
| 2023-09-30 | $663,714 | 48,411 | Shares | Sole | 2023-11-09 | |
| 2023-06-30 | $692,573 | 43,151 | Shares | Sole | 2023-08-08 | |
| 2023-03-31 | $211,801 | 27,294 | Shares | Sole | 2023-05-11 | |
| 2022-12-31 | $349,325 | 18,053 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $375,056 | 17,600 | Shares | Sole | 2022-11-10 | |
| 2022-06-30 | $221,461 | 16,272 | Shares | Sole | 2022-08-11 | |
| 2022-03-31 | $243,943 | 10,385 | Shares | Sole | 2022-05-12 | |
| No filing history on record for this holder in this stock. | ||||||